HealthCap VII L.P. 13D and 13G filings for Fusion Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-03-20 6:08 pm Unchanged |
2024-03-18 | 13D | Fusion Pharmaceuticals Inc. FUSN |
HealthCap VII L.P. | 3,807,247 4.500% |
0 (Unchanged) |
Filing |
2024-03-07 4:05 pm Unchanged |
2024-03-07 | 13D | Fusion Pharmaceuticals Inc. FUSN |
HealthCap VII L.P. | 3,807,247 5.300% |
0 (Unchanged) |
Filing |
2023-03-06 4:06 pm Unchanged |
2023-02-16 | 13D | Fusion Pharmaceuticals Inc. FUSN |
HealthCap VII L.P. | 3,807,247 6.100% |
0 (Unchanged) |
Filing |
2020-07-10 5:00 pm Purchase |
2020-06-30 | 13D | Fusion Pharmaceuticals Inc. FUSN |
HealthCap VII L.P. | 3,807,247 9.100% |
3,807,247![]() (New Position) |
Filing |